DEFA14A: InMed Pharmaceuticals Announces Notice-and-Access for 2024 Annual General Meeting

InMed Pharmaceuticals will hold its 2024 Annual General Meeting virtually on December 18, 2024, and is using notice-and-access rules for delivering meeting materials to shareholders.

Summary

• InMed Pharmaceuticals Inc. is using notice-and-access rules to deliver meeting materials for its 2024 Annual General Meeting to registered and beneficial shareholders.
• The meeting will be held virtually on December 18, 2024, at 4:00 p.m. (PST) via telephone conference.
• Shareholders of record as of October 21, 2024, can submit their votes until 4:00 p.m. (PST) on December 16, 2024.
• The purposes of the meeting include receiving the audited financial statements for the fiscal year ended June 30, 2024, electing directors, appointing Marcum LLP as the auditor, and transacting other business.
• Shareholders can access the proxy materials at www.inmedpharma.com and www.SEDARPlus.com.
• Voting can be done online, by e-mail, by phone, by fax, or by mail, following the instructions on the voting instruction form or proxy form.
• Requests for paper or e-mail copies of the meeting materials can be made to Odyssey Trust Company until five business days before the proxy cut-off date.

Sentiment

Score: 7

Explanation: The document is a standard notification for an annual general meeting, conveying neutral information with a slightly positive tone due to the emphasis on environmental responsibility and cost reduction.

Positives

• The use of notice-and-access reduces paper use and the company's printing and mailing costs, making it more environmentally responsible.
• Shareholders have multiple options for voting, including online, e-mail, phone, fax, and mail, providing flexibility and convenience.
• The company provides clear instructions on how to access meeting materials and vote.

Risks

• Shareholders who do not request paper copies of the meeting materials will not receive them.
• Technical issues could potentially disrupt the virtual meeting.

Future Outlook

The company will continue to hold annual general meetings to conduct standard corporate governance activities.

Management Comments

• Management and the board recommend a vote for each nominee and for each matter to be voted on.
• We encourage you to access and review all of the important information contained in the proxy materials before voting.

Industry Context

The use of notice-and-access is a common practice among publicly traded companies to reduce costs and environmental impact while ensuring shareholders have access to important meeting materials.

Stakeholder Impact

• Shareholders are encouraged to participate in the voting process.
• The use of notice-and-access aims to reduce costs for the company, potentially benefiting shareholders.
• The environmentally responsible approach aligns with stakeholder interests in sustainability.

Next Steps

• Shareholders should review the proxy materials and vote before the proxy cut-off date.
• The company will hold the Annual General Meeting on December 18, 2024.
• The company will announce the results of the votes after the meeting.

Key Dates

Keywords

Annual General Meeting, Proxy Statement, Shareholders, Voting, InMed Pharmaceuticals, Notice-and-access